ATE409462T1 - Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer - Google Patents
Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymerInfo
- Publication number
- ATE409462T1 ATE409462T1 AT05742034T AT05742034T ATE409462T1 AT E409462 T1 ATE409462 T1 AT E409462T1 AT 05742034 T AT05742034 T AT 05742034T AT 05742034 T AT05742034 T AT 05742034T AT E409462 T1 ATE409462 T1 AT E409462T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- improved performance
- polymers
- hpmca
- performance containing
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 hydroxypropoxy, methoxy, acetyl Chemical class 0.000 abstract 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/08—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with hydroxylated hydrocarbon radicals; Esters, ethers, or acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
- C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57554104P | 2004-05-28 | 2004-05-28 | |
| US58654904P | 2004-07-09 | 2004-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE409462T1 true ATE409462T1 (de) | 2008-10-15 |
Family
ID=35451370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05742034T ATE409462T1 (de) | 2004-05-28 | 2005-05-18 | Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8207232B2 (de) |
| EP (1) | EP1753402B1 (de) |
| JP (1) | JP2008501009A (de) |
| AT (1) | ATE409462T1 (de) |
| CA (1) | CA2568007A1 (de) |
| DE (1) | DE602005010074D1 (de) |
| MX (1) | MXPA06013891A (de) |
| WO (1) | WO2005115330A2 (de) |
Families Citing this family (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004534812A (ja) * | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 薬物および中性ポリマーの分散物の医薬組成物 |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| JP2010526848A (ja) * | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| WO2009125415A1 (en) * | 2008-04-07 | 2009-10-15 | Hetero Research Foundation | Amorphous form of sildenafil citrate |
| US8685458B2 (en) | 2009-03-05 | 2014-04-01 | Bend Research, Inc. | Pharmaceutical compositions of dextran polymer derivatives |
| EP2411137B1 (de) | 2009-03-27 | 2016-09-07 | Bend Research, Inc. | Sprühtrocknungsverfahren |
| KR101682466B1 (ko) * | 2010-02-01 | 2016-12-05 | 롯데정밀화학 주식회사 | 아세틸화 셀룰로오스 에테르 및 이를 포함하는 물품 |
| WO2011148253A2 (en) | 2010-05-25 | 2011-12-01 | Aurobindo Pharma Limited | Solid dosage forms of antipsychotics |
| JP5792807B2 (ja) * | 2010-06-14 | 2015-10-14 | ダウ グローバル テクノロジーズ エルエルシー | アセテートおよびサクシネートの置換が向上されたヒドロキシプロピルメチルセルロースアセテートサクシネート |
| EP2611529B1 (de) | 2010-09-03 | 2019-01-23 | Bend Research, Inc. | Sprühtrocknungsverfahren |
| WO2012031133A2 (en) | 2010-09-03 | 2012-03-08 | Bench Research, Inc. | Spray-drying apparatus and methods of using the same |
| WO2012040502A1 (en) | 2010-09-24 | 2012-03-29 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
| KR101088845B1 (ko) * | 2011-01-21 | 2011-12-06 | 원광대학교산학협력단 | 황금 추출물의 속효성 고체 분산체, 이를 함유한 경구용 제제 및 이들의 제조방법 |
| US8591944B2 (en) | 2011-03-08 | 2013-11-26 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| US9060938B2 (en) | 2011-05-10 | 2015-06-23 | Bend Research, Inc. | Pharmaceutical compositions of active agents and cationic dextran polymer derivatives |
| WO2013148154A1 (en) | 2012-03-27 | 2013-10-03 | Dow Global Technologies Llc | A process of preparing an ester of a cellulose ether |
| CN104364268B (zh) | 2012-04-11 | 2016-07-20 | 陶氏环球技术有限责任公司 | 包含纤维素醚的熔融挤出的组合物 |
| CN104427979B (zh) * | 2012-04-11 | 2018-02-16 | 陶氏环球技术有限责任公司 | 具有特定的取代基分布的酯化的纤维素醚 |
| JP5809379B2 (ja) | 2012-04-11 | 2015-11-10 | ダウ グローバル テクノロジーズ エルエルシー | 新規徐放剤形 |
| JP6185559B2 (ja) * | 2012-04-11 | 2017-08-23 | ダウ グローバル テクノロジーズ エルエルシー | 有機希釈剤およびセルロースエーテルを含む組成物 |
| US9962446B2 (en) | 2012-07-17 | 2018-05-08 | Dow Global Technologies Llc | Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose |
| BR112014031471B1 (pt) | 2012-07-17 | 2020-12-01 | Dow Global Technologies Llc | composição líquida, uso da composição líquida, dispersão sólida, processo para produzir a dispersão sólida e processo para revestir uma forma de dosagem |
| CN102807625A (zh) * | 2012-08-23 | 2012-12-05 | 浙江中维药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的制备方法 |
| KR102138546B1 (ko) * | 2012-08-24 | 2020-07-28 | 다우 글로벌 테크놀로지스 엘엘씨 | 부분적으로 가교결합된 에스테르화된 셀룰로즈 에테르 |
| JP6166372B2 (ja) | 2012-08-24 | 2017-07-19 | ダウ グローバル テクノロジーズ エルエルシー | アルカリ金属カルボン酸塩および脂肪族カルボン酸の存在下でエステル化セルロースエーテルを調製するためのプロセス |
| MX374548B (es) * | 2012-08-24 | 2025-03-06 | Dow Global Technologies Llc | Eteres de celulosa esterificados novedosos de alto peso molecular y homogeneidad. |
| CN104755503B (zh) | 2012-08-24 | 2018-03-06 | 陶氏环球技术有限责任公司 | 在脂族羧酸的存在下制备纤维素醚的酯的方法 |
| MX2015002430A (es) * | 2012-08-24 | 2015-06-22 | Dow Global Technologies Llc | Acetato-succinatos de hidroxialquilmetilcelulosa. |
| WO2014126969A1 (en) | 2013-02-12 | 2014-08-21 | Bend Research, Inc. | Solid dispersions of low-water solubility actives |
| US9737538B2 (en) * | 2013-02-12 | 2017-08-22 | Bend Research, Inc. | Solid dispersions of low-water solubility actives |
| US9492550B2 (en) | 2013-03-01 | 2016-11-15 | Hercules Llc | Pharmaceutical compositions with enhanced performance and improved processability |
| WO2014137777A1 (en) | 2013-03-07 | 2014-09-12 | Dow Global Technologies Llc | Novel esterified cellulose ethers of low viscosity |
| KR101661952B1 (ko) * | 2013-03-07 | 2016-10-04 | 다우 글로벌 테크놀로지스 엘엘씨 | 극저점도의 신규한 에스테르화된 셀룰로스 에테르 |
| BR112015019354A2 (pt) * | 2013-03-07 | 2017-07-18 | Dow Global Technologies Llc | acetato succinato de hidroxipropil metilcelulose, composição, dispersão sólida, forma de dosagem, envoltório de cápsula e processo para produzir um acetato succinato de hidroxipropil metilcelulose |
| EP2964203B1 (de) * | 2013-03-07 | 2019-04-03 | Dow Global Technologies LLC | Neuartige veresterte celluloseether mit sehr hohem molekulargewicht |
| BR112015024522A8 (pt) | 2013-05-14 | 2019-12-10 | Dow Global Technologies Llc | éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir o éter de celulose esterificado |
| PT3006049T (pt) | 2013-06-03 | 2018-03-20 | Shinetsu Chemical Co | Composição para extrusão por fusão a quente e método para produzir um produto extrudido por fusão a quente |
| KR101674912B1 (ko) * | 2013-09-23 | 2016-11-10 | 다우 글로벌 테크놀로지스 엘엘씨 | 반응 생성물 혼합물로부터 에스테르화된 셀룰로스 에테르를 회수하기 위한 방법 |
| CN105530918A (zh) | 2013-09-25 | 2016-04-27 | 陶氏环球技术有限责任公司 | 包含有机液体稀释剂和特定羟烷基甲基纤维素的组合物 |
| WO2015061602A1 (en) | 2013-10-23 | 2015-04-30 | Dow Global Technologies Llc | Methods, systems, and devices for designing molecules |
| EP3090749B1 (de) * | 2013-12-20 | 2023-08-30 | Daicel Corporation | Nährstoffzusammensetzung mit wirkung zur verbesserung des fettstoffwechsels |
| KR102286952B1 (ko) * | 2013-12-31 | 2021-08-09 | 롯데정밀화학 주식회사 | 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말 |
| WO2015126576A1 (en) | 2014-02-20 | 2015-08-27 | Dow Global Technologies Llc | Novel esterified cellulose ethers of high molecular weight and homogeneity |
| US10300085B2 (en) * | 2014-03-24 | 2019-05-28 | Daicel Corporation | Nutritional composition |
| GR1008554B (el) | 2014-06-12 | 2015-09-03 | ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, | Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου |
| MX2017002073A (es) | 2014-08-27 | 2017-05-25 | Dow Global Technologies Llc | Eteres de celulosa esterificados con bajo contenido insoluble en acetona. |
| WO2016067132A1 (en) | 2014-10-31 | 2016-05-06 | Bend Research Inc. | Process for forming active domains dispersed in a matrix |
| MX356115B (es) * | 2014-10-31 | 2018-05-15 | Dow Global Technologies Llc | Proceso para producir un succinato de acetato de eter de celulosa. |
| MX355025B (es) | 2014-10-31 | 2018-04-02 | Dow Global Technologies Llc | Proceso eficiente para preparar ester de eter de celulosa. |
| CN107074980A (zh) | 2014-10-31 | 2017-08-18 | 陶氏环球技术有限责任公司 | 制备纤维素醚的酯的方法 |
| JP6203702B2 (ja) * | 2014-11-18 | 2017-09-27 | 信越化学工業株式会社 | ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法 |
| JP6271817B1 (ja) | 2015-01-08 | 2018-01-31 | ダウ グローバル テクノロジーズ エルエルシー | 水不溶性粒子の含有量を減少させた水溶性セルロース誘導体を生成するための方法 |
| US20180030157A1 (en) | 2015-03-16 | 2018-02-01 | Dow Global Technologies Llc | Process for fractionating an esterified cellulose ether |
| KR20170128349A (ko) | 2015-03-16 | 2017-11-22 | 다우 글로벌 테크놀로지스 엘엘씨 | 지방족 카복실산의 존재하에서의 에스테르화된 셀룰로오스 에테르의 제조 방법 |
| KR20170128350A (ko) | 2015-03-16 | 2017-11-22 | 다우 글로벌 테크놀로지스 엘엘씨 | 에스테르화된 셀룰로오스 에테르의 수용액 |
| EP3270970B1 (de) | 2015-03-16 | 2019-01-09 | Dow Global Technologies LLC | Gelierung von veresterten celluloseethern |
| JP6356922B2 (ja) | 2015-03-16 | 2018-07-11 | ダウ グローバル テクノロジーズ エルエルシー | 低い中和度を有する水溶性エステル化セルロースエーテル |
| BR112017018232A2 (pt) | 2015-03-16 | 2018-04-17 | Dow Global Technologies Llc | éteres de celulose esterificados solúveis em água |
| KR20180008524A (ko) * | 2015-05-15 | 2018-01-24 | 다우 글로벌 테크놀로지스 엘엘씨 | 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법 |
| BR112017023845A2 (pt) | 2015-05-15 | 2018-07-31 | Dow Global Technologies Llc | processo de preparação de um éter de celulose esterificado de peso molecular elevado |
| KR20180056668A (ko) | 2015-09-24 | 2018-05-29 | 다우 글로벌 테크놀로지스 엘엘씨 | 아세트산과 반응 촉매의 존재하에서 셀룰로오스 에테르의 에스테르를 제조하기 위한 방법 |
| WO2017058973A1 (en) | 2015-10-02 | 2017-04-06 | Dow Global Technologies Llc | Aqueous composition comprising dispersed esterified cellulose ether |
| EP3386481A1 (de) | 2015-12-08 | 2018-10-17 | Dow Global Technologies Llc | Zusammensetzungen mit celluloseether und wasserlöslichen veresterten celluloseethern |
| WO2017146853A1 (en) | 2016-02-24 | 2017-08-31 | Dow Global Technologies Llc | Aqueous composition comprising water-soluble esterified cellulose ethers |
| US10604588B2 (en) * | 2016-04-05 | 2020-03-31 | Shin-Etsu Chemical Co., Ltd. | Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid preparation |
| AU2017248828A1 (en) | 2016-04-15 | 2018-11-01 | Janssen Sciences Ireland Uc | Combinations and methods comprising a capsid assembly inhibitor |
| KR20190013815A (ko) | 2016-05-25 | 2019-02-11 | 다우 글로벌 테크놀로지스 엘엘씨 | 셀룰로스 에터 아세테이트의 수용액 |
| GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
| WO2017223018A1 (en) | 2016-06-23 | 2017-12-28 | Dow Global Technologies Llc | Esterified cellulose ethers comprising trimellityl groups |
| JP6548287B2 (ja) | 2016-06-23 | 2019-07-24 | ダウ グローバル テクノロジーズ エルエルシー | フタリル基を含むエステル化セルロースエーテル |
| CN106317229A (zh) * | 2016-08-22 | 2017-01-11 | 四川北方硝化棉股份有限公司 | 一种制备低取代度醋酸纤维素的生产方法 |
| WO2018039214A1 (en) | 2016-08-23 | 2018-03-01 | Dow Global Technologies Llc | Esterified cellulose ethers comprising maleyl groups |
| BR112019003048A2 (pt) | 2016-08-23 | 2019-05-21 | Dow Global Technologies Llc | ftalato de acetato de éter de celulose |
| BR112019007136A2 (pt) | 2016-10-18 | 2019-07-02 | Dow Global Technologies Llc | processo eficiente para preparação de um éter de celulose esterificado |
| KR102490265B1 (ko) * | 2016-11-02 | 2023-01-20 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 히프로멜로오스아세트산에스테르숙신산에스테르 및 제조 방법 |
| JP2020511572A (ja) | 2017-03-17 | 2020-04-16 | ダウ グローバル テクノロジーズ エルエルシー | 反応生成物混合物からのエステル化セルロースエーテルの回収方法 |
| WO2018170083A1 (en) | 2017-03-17 | 2018-09-20 | Dow Global Technologies Llc | Process for recovering an esterified cellulose ether from a reaction product mixture |
| CN110366566B (zh) | 2017-03-17 | 2021-08-13 | 陶氏环球技术有限责任公司 | 用于从反应产物混合物中回收酯化纤维素醚的方法 |
| MX2020009531A (es) | 2018-03-14 | 2020-10-05 | Janssen Sciences Ireland Unlimited Co | Regimen posologico del modulador del ensamblaje de la capside. |
| CA3098306C (en) * | 2018-05-14 | 2024-04-16 | Capsugel Belgium Nv | Solid dosage forms with high active agent loading |
| WO2020117736A1 (en) | 2018-12-04 | 2020-06-11 | DDP Specialty Electronic Materials US, Inc. | Hydroxypropyl methylcellulose acetate succinates of very high molecular weight |
| WO2020131801A1 (en) * | 2018-12-18 | 2020-06-25 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
| WO2020131785A1 (en) * | 2018-12-18 | 2020-06-25 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
| US12576033B2 (en) * | 2019-04-11 | 2026-03-17 | Gfb (Abc), Llc | Spray-dried formulation of a pyridazinone TRPC5 inhibitor |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
| WO2021118915A1 (en) | 2019-12-09 | 2021-06-17 | Nutrition & Biosciences Usa 1, Llc | Hydroxypropyl alkyl cellulose acetate succinate heteropolymers |
| WO2021118917A1 (en) | 2019-12-09 | 2021-06-17 | Nutrition & Biosciences Usa 1, Llc | Composition comprising a highly substituted hydroxypropyl methylcellulose and a sugar alcohol |
| IL294928A (en) | 2020-01-24 | 2022-09-01 | Nanocopoeia Llc | Amorphous solid dispersions of dasatinib and uses thereof |
| EP4096791A1 (de) | 2020-01-31 | 2022-12-07 | Nanocopoeia LLC | Amorphe nilotinib-mikropartikel und deren verwendungen |
| WO2021222739A1 (en) | 2020-04-30 | 2021-11-04 | Nanocopoeia, Llc | Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib |
| JP2024520798A (ja) * | 2021-06-09 | 2024-05-24 | ロンザ・ベンド・インコーポレーテッド | 非晶質固体分散体の調製のための噴霧乾燥のための混合溶媒 |
| US11980619B2 (en) | 2021-07-28 | 2024-05-14 | Nanocopoeia, Llc | Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226981A (en) * | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
| JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
| JP2528706B2 (ja) * | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
| WO1992018106A1 (fr) * | 1991-04-16 | 1992-10-29 | Nippon Shinyaku Co., Ltd. | Procede de production d'une dispersion solide |
| JP3149122B2 (ja) | 1994-11-07 | 2001-03-26 | 信越化学工業株式会社 | 固形腸溶製剤のコーティング用基剤 |
| JP3149125B2 (ja) * | 1995-05-01 | 2001-03-26 | 信越化学工業株式会社 | 固形腸溶製剤のコーティング用基剤 |
| ES2287971T3 (es) * | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
| ATE400251T1 (de) * | 1999-02-09 | 2008-07-15 | Pfizer Prod Inc | Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit |
| ATE400252T1 (de) | 1999-02-10 | 2008-07-15 | Pfizer Prod Inc | Pharmazeutische feste dispersionen |
| US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| AU2002212102A1 (en) * | 2000-11-08 | 2002-05-21 | Aeromatic-Fielder Ag | A process for production of particles for pharmaceutical compositions having increased bioavailability |
| TNSN03137A1 (en) * | 2001-06-22 | 2005-12-23 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS. |
| PL372247A1 (en) | 2002-02-01 | 2005-07-11 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| MXPA06002455A (es) | 2003-09-02 | 2006-08-31 | Pfizer Prod Inc | Formas de dosificacion de liberacion sostenida de ziprasidona. |
| WO2005102092A1 (ja) | 2004-04-20 | 2005-11-03 | Urban-Nawachi Co., Ltd | 靴構造の履物 |
-
2005
- 2005-05-18 CA CA002568007A patent/CA2568007A1/en not_active Abandoned
- 2005-05-18 EP EP05742034A patent/EP1753402B1/de not_active Expired - Lifetime
- 2005-05-18 MX MXPA06013891A patent/MXPA06013891A/es not_active Application Discontinuation
- 2005-05-18 JP JP2007514203A patent/JP2008501009A/ja active Pending
- 2005-05-18 DE DE602005010074T patent/DE602005010074D1/de not_active Expired - Fee Related
- 2005-05-18 WO PCT/IB2005/001580 patent/WO2005115330A2/en not_active Ceased
- 2005-05-18 AT AT05742034T patent/ATE409462T1/de not_active IP Right Cessation
- 2005-05-18 US US11/569,433 patent/US8207232B2/en not_active Expired - Fee Related
-
2012
- 2012-06-26 US US13/533,637 patent/US8940800B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20080262107A1 (en) | 2008-10-23 |
| WO2005115330A3 (en) | 2006-07-06 |
| MXPA06013891A (es) | 2007-01-26 |
| JP2008501009A (ja) | 2008-01-17 |
| DE602005010074D1 (de) | 2008-11-13 |
| WO2005115330A2 (en) | 2005-12-08 |
| US8940800B2 (en) | 2015-01-27 |
| EP1753402A2 (de) | 2007-02-21 |
| EP1753402B1 (de) | 2008-10-01 |
| US20120264833A1 (en) | 2012-10-18 |
| US8207232B2 (en) | 2012-06-26 |
| CA2568007A1 (en) | 2005-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE409462T1 (de) | Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer | |
| MX2012014849A (es) | Acetato succinato de hidroxipropil metil celulosa con substitucion de acetato de y succinato intensificada. | |
| ATE444060T1 (de) | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren | |
| AR048331A1 (es) | Sistema de administracion de farmacos con retencion gastrica | |
| WO2008149440A1 (ja) | 速溶性及び可撓性を有するフィルム製剤 | |
| CY1112268T1 (el) | Σκευασμα δισκιου παρατεταμενης αποδεσμευσης περιεχον πραμιπεξολη ή ενα φαρμακευτικως αποδεκτο αλας αυτης | |
| NO20022998D0 (no) | Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament | |
| DE602004017490D1 (de) | Medizinische vorrichtungen | |
| EA200301250A1 (ru) | Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры | |
| WO2006005058A3 (en) | Polymer-factor ix moiety conjugates | |
| NO20070779L (no) | Farmasoytiske doseringsformer omfattende et lavt-loselig medikament og en polymer | |
| DE602007002295D1 (de) | Arzneimittelabgabevorrichtung | |
| DE602005026395D1 (de) | Neue zyklische harnstoffderivate, deren herstellung und pharmazeutische verwendung damit als kinase-inhibitoren | |
| NO20064570L (no) | Farmasoytiske preparater | |
| DE60026357D1 (de) | An- und abschwellende polymermischungen | |
| NO20082097L (no) | Farmasoytiske sammensetninger | |
| BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
| ATE378042T1 (de) | Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln | |
| EP1689419A4 (de) | Pharmazeutische zusammensetzungen mit niedrigen dosen von desmopressin | |
| ATE500819T1 (de) | Stabilisierte pharmazeutische feste zusammensetzungen von arzneimitteln mit geringer löslichkeit, poloxameren und stabilisierenden polymeren | |
| EP1869190A4 (de) | Genzuführungssystem mit decorin-gen und das system enthaltende pharmazeutische zusammensetzung zur krebsbehandlung | |
| ITMI20032087A1 (it) | Film autosupportanti per uso farmaceutico ed alimentare. | |
| MA27879A1 (fr) | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique | |
| BRPI0511583A (pt) | composições farmacêuticas com desempenho aumentado | |
| TW200514571A (en) | Pharmaceutical composition with improved solubility and fluidity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |